📰 Exact Sciences News
Page 43 - Exact Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exact Sciences. Real-time updates on events, politics, business and more.
July 5, 2023
Wayfair, Palantir, and Nvidia stocks were among the biggest gainers during the second quarter.
July 1, 2023
Gratus Capital LLC acquired a new stake in Exact Sciences Co. (NASDAQ:EXAS – Free Report) in the 1st quarter, Holdings Channel reports. The fund acquired 5,000 shares of the medical research company’s stock, valued at approximately $339,000. Several other hedge funds and other institutional investors have also recently modified their holdings of the stock. American […]
June 30, 2023
Fund manager Dani Saurymper says aging is an investable area today that will become "increasingly more relevant and apparent."
June 28, 2023
Is it a matter of time before Exact Sciences stock starts giving back some of its impressive gains this year?
June 25, 2023
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target raised by Craig Hallum from $85.00 to $106.00 in a research report report published on Thursday, The Fly reports. A number of other analysts have also recently weighed in on the company. Benchmark increased their price target on Exact Sciences from $81.00 to $96.00 in […]
June 25, 2023
Exact Sciences (NASDAQ:EXAS – Get Rating) had its target price lifted by Benchmark from $81.00 to $96.00 in a report released on Thursday, The Fly reports. EXAS has been the topic of a number of other reports. Credit Suisse Group restated a neutral rating and set a $70.00 price target on shares of Exact Sciences […]
June 25, 2023
1-800-FLOWERS.COM restated their reiterates rating on shares of Exact Sciences (NASDAQ:EXAS – Get Rating) in a research report released on Thursday morning, Benzinga reports. Other equities analysts have also issued research reports about the company. BTIG Research boosted their price objective on Exact Sciences from $95.00 to $110.00 in a research note on Thursday. Cowen […]
June 25, 2023
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price objective raised by Benchmark from $81.00 to $96.00 in a research note issued to investors on Thursday, The Fly reports. EXAS has been the subject of a number of other reports. Craig Hallum upgraded shares of Exact Sciences from a hold rating to a buy rating […]
June 25, 2023
Exact Sciences (NASDAQ:EXAS – Get Rating) had its price target boosted by Stifel Nicolaus from $85.00 to $120.00 in a report released on Thursday, The Fly reports. A number of other research analysts have also recently commented on the stock. Piper Sandler increased their price target on shares of Exact Sciences from $70.00 to $80.00 […]